|Comprehensive molecular portraits of human breast tumours|
Cancer Genome Atlas Network
Nature 490 (7418), 61, 2012
|The cancer genome atlas pan-cancer analysis project|
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113, 2013
|Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin|
KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ...
Cell 158 (4), 929-944, 2014
|Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling|
W Zhao, X He, KA Hoadley, JS Parker, DN Hayes, CM Perou
BMC genomics 15 (1), 1-11, 2014
|Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells|
JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ...
Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012
|ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade|
J Shen, Z Ju, W Zhao, L Wang, Y Peng, Z Ge, ZD Nagel, J Zou, C Wang, ...
Nature medicine 24 (5), 556-562, 2018
|Characterization of human cancer cell lines by reverse-phase protein arrays|
J Li, W Zhao, R Akbani, W Liu, Z Ju, S Ling, CP Vellano, P Roebuck, Q Yu, ...
Cancer cell 31 (2), 225-239, 2017
|PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness|
J Shen, W Zhao, Z Ju, L Wang, Y Peng, M Labrie, TA Yap, GB Mills, ...
Cancer research 79 (2), 311-319, 2019
|Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer|
K Xu, J Usary, PC Kousis, A Prat, DY Wang, JR Adams, W Wang, AJ Loch, ...
Cancer cell 21 (5), 626-641, 2012
|BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency|
C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ...
Cancer cell 33 (3), 401-416. e8, 2018
|Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases|
KA Hoadley, MB Siegel, KL Kanchi, CA Miller, L Ding, W Zhao, X He, ...
PLoS medicine 13 (12), e1002174, 2016
|Predicting drug responsiveness in human cancers using genetically engineered mice|
J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ...
Clinical Cancer Research 19 (17), 4889-4899, 2013
|Functional variomics and network perturbation: connecting genotype to phenotype in cancer|
S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni
Nature Reviews Genetics 18 (7), 395-410, 2017
|Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome|
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19 (1), 44, 2017
|Breast cancer quantitative proteome and proteogenomic landscape|
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1-14, 2019
|Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas|
J Li, R Akbani, W Zhao, Y Lu, JN Weinstein, GB Mills, H Liang
Cancer research 77 (21), e51-e54, 2017
|Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes|
DH Nguyen, E Fredlund, W Zhao, CM Perou, A Balmain, JH Mao, ...
Clinical Cancer Research 19 (6), 1353-1362, 2013
|Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT|
S Mitra, L Federico, W Zhao, J Dennison, TR Sarkar, F Zhang, V Takiar, ...
Oncotarget 7 (26), 40252, 2016
|Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer|
HH Chao, X He, JS Parker, W Zhao, CM Perou
PloS one 7 (12), e51719, 2012
|Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening|
G Han, W Zhao, X Song, PKS Ng, JA Karam, E Jonasch, GB Mills, Z Zhao, ...
BMC genomics 18 (6), 678, 2017